SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
bobbseytwins2001
gaduntz73
watchmymovement
To: Teetime who wrote (31315)7/8/2015 1:24:43 PM
From: Fitzhughlaw3 Recommendations  Read Replies (1) of 63324
 
Dearest Tee, I watch a number of "development stage" biotech stocks, just to gauge the veracity of the quotidian IMMU excuse whenever the stock tanks on a day like this ("it's the market"), and as always, we are the leader on a down day. Other similarly-situated companies are down between 2.5 and 4% (and by "similarly situated," I don't mean one wherein the CEO got the job by being the mistress of the COB,* but rather, those that have not brought a product to market).

What days like this really drive home is just how frustrating it is that because of the incompetence and corruption of IMMU's management, the company did not participate in the biggest bull market of biotech stocks ever. Had we done that, and were now getting beat up a bit like every other company, this would be easy to take with a shrug of the shoulders, but because IMMU merely tread water for years, we participate only the market's correction.

* There I go being "derisive, hateful and name calling" again, according to a poster who joined here just over a year ago, and thus has not suffered both the rapacious mendacity, and almost unfathomable incompetence of, the Goldenbergs for a decade or more.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext